IRIS - Res&Arch Institutional Research Information System - Research & Archive

BIANCHI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.279
EU - Europa 2.105
AS - Asia 430
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
Totale 4.835
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.275
IT - Italia 477
IE - Irlanda 393
UA - Ucraina 390
SE - Svezia 288
HK - Hong Kong 183
VN - Vietnam 135
RO - Romania 111
DE - Germania 98
FI - Finlandia 93
FR - Francia 86
CN - Cina 76
RU - Federazione Russa 71
GB - Regno Unito 31
BE - Belgio 24
CH - Svizzera 15
CI - Costa d'Avorio 14
GR - Grecia 11
TR - Turchia 11
UZ - Uzbekistan 9
IN - India 7
LB - Libano 6
NL - Olanda 6
AT - Austria 4
EU - Europa 4
BR - Brasile 2
CA - Canada 2
CZ - Repubblica Ceca 2
MX - Messico 2
PL - Polonia 2
HU - Ungheria 1
JP - Giappone 1
KR - Corea 1
LK - Sri Lanka 1
LV - Lettonia 1
NG - Nigeria 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.835
Salva come PNG Salva come JPEG
Città #
Chandler 427
Dublin 393
Perugia 282
San Mateo 232
Jacksonville 191
Hong Kong 183
Dong Ket 135
Bucharest 111
Wilmington 97
Medford 94
Princeton 93
Altamura 89
Redmond 89
Ann Arbor 77
Andover 70
Des Moines 69
Lawrence 68
Beijing 56
Falls Church 45
Boardman 40
Dearborn 34
Woodbridge 27
Pisa 26
Saint Petersburg 26
Brussels 24
Norwalk 22
Ashburn 19
Fremont 16
New York 16
Abidjan 14
San Paolo di Civitate 14
Izmir 10
San Diego 9
Helsinki 8
Los Angeles 7
Den Haag 6
Hanover 6
Moscow 6
Nanjing 5
Redwood City 5
Nagpur 4
Tappahannock 4
Auburn Hills 3
Chicago 3
Frankfurt Am Main 3
Jinan 3
Nichelino 3
Nürnberg 3
Paris 3
Spoleto 3
Cambridge 2
Edinburgh 2
Houston 2
Lausanne 2
Ludwigshafen 2
Milan 2
Nanchang 2
Planegg 2
Pune 2
Rio De Janeiro 2
Saint Louis 2
San Jose 2
Silea 2
Terni 2
Vicenza 2
Wuhan 2
Athens 1
Azcapotzalco 1
Boston 1
Bratislava 1
Budapest 1
Cagliari 1
Carrollton 1
Castel Maggiore 1
Chengdu 1
Civitanova Marche 1
Dallas 1
Dambulla 1
Denver 1
Fairfield 1
Freiburg 1
Gaziantep 1
Genova 1
Kraków 1
Kunming 1
Lagos 1
Lappeenranta 1
Libertyville 1
Lugano 1
Ningbo 1
Nottingham 1
Nuremberg 1
Ottawa 1
Riga 1
Shanghai 1
Simi Valley 1
Southend 1
Spin 1
Tavernelle 1
Turin 1
Totale 3.239
Salva come PNG Salva come JPEG
Nome #
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 131
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 123
A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression. 116
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 114
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 113
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 111
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 106
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 102
IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 100
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 97
The TGF-β/IDO axis in infectious tolerance. 84
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 83
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 79
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice 76
A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. 76
CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide 75
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 75
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 74
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 72
IL-12 acts selectively on CD8a- dendritic cells to enhance presentation of a tumor peptide in vivo 71
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 71
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 69
Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis 69
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 67
Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation 66
Adoptive immunotherapy of intracerebral murine lymphomas: role of different lymphoid populations. 66
Antigen-specific immunoregulation by IL-35Ig-transfected dendritic cells 65
Modulation of tryptophan catabolism by regulatory T cells 64
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. 62
Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. 61
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 61
O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia 60
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. 58
Ectopic expression of IL-35Ig by dendritic cells induces tolerance via Arginase 1. 58
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. 56
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 56
Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity. 55
Systemic adoptive immunotherapy of a highly immunogenic murine lymphoma growing in the brain. 54
[Experimental models of immunochemotherapeutic synergism: study of the influence of the treatment schedule]. 52
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 51
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 51
T cell apoptosis by tryptophan catabolism 50
Immunobiological aspects of the nude mouse model relative to human cancer chemosensitivity tests. 50
IL-12 is both required and sufficient for initiating T-cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells 50
Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine 49
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. 48
Towards the identification of a tolerogenic signature in IDO-competent dendritic cells 48
Tumor-specific L3T4+ and Lyt-2+ lymphocytes in mice primed to mutagenized cell variants. 48
CTLA-4-Ig regulates tryptophan catabolism in vivo. 47
Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization. 47
CD40 ligand and CTLA-4 are reciprocally regulated in the Th1 cell proliferative response sustained by CD8+ dendritic cells. 46
[Transfer in vivo of cytotoxic immune lymphocytes obtained in vitro in primary culture against a murine lymphoma antigenically altered by DTIC]. 46
IL-12 ACTS DIRECTLY ON DC TO PROMOTE NUCLEAR LOCALIZATION OF NF-kB AND PRIMES DC FOR IL-12 PRODUCTION 46
Immunomodulatory properties of ribavirin in the mouse. 45
A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state 45
Dendritic cells, CD4+ lymphocytes and IL-12 in an experimental model of antitumor immunotherapy 44
CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. 43
Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. 42
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 42
Immunogenic properties of retroviral protein p15E from drug-treated murine mastocytoma P815 41
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 41
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12 41
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells 40
IL-23 and IL-12 have overlapping but distinct effects on murine dendritic cells. 39
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 39
Molecular and genomic aspects of xenogenizing-alkylating drugs. 39
Use of a skin test assay to determine tumor-specific CD8+ T cell reactivity 38
O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents. 38
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 37
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. 36
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 36
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 35
Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo. 35
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 35
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 34
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 34
Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex 33
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 33
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice 33
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma 32
Tryptophan catabolism in nonobese diabetic mice. 32
Indoleamine 2,3-dioxygenase: from catalyst to signaling function 31
Dendritic cells and interleukin 12 as adjuvants for tumor-specific vaccines. 31
Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement 31
Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variant. 30
IL-12 induces SDS-stable class II (alpha beta) dimers in murine dendritic cells 29
Induction of tumor suppression and delayed-type footpad reaction by transfer of lymphocytes sensitized to a xenogenized tumor variant. 27
PROTEASOME INHIBITION IN pDCs CONFERS AN IDO-DEPENDENT IMMUNOREGULATORY PHENOTYPE 23
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION 22
IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha- dendritic cells via potentation of the CD8 alpha+ subset 21
Th1 and Th2 cell clones to poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo 21
Indoleamine 2,3 dioxygnenase: as an inducer and amplifier of regulatory T cell functions. 19
The role of IL-12 in the induction of an immune response to a tumor/self peptide: prevention and reversion of anergy. 18
Totale 5.090
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.149
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201930 0 0 0 0 0 0 0 0 0 3 23 4
2019/2020554 15 8 72 9 59 36 85 20 109 56 23 62
2020/2021978 6 59 33 59 285 68 93 5 109 41 69 151
2021/20221.141 15 160 12 52 56 32 14 277 108 88 107 220
2022/20231.462 107 249 15 116 137 187 0 77 515 5 41 13
2023/2024385 35 85 15 9 3 9 150 17 50 12 0 0
Totale 5.090